These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 11365477)

  • 41. Viramune cleared for use in combination with protease inhibitors.
    AIDS Patient Care STDS; 1998 Nov; 12(11):872. PubMed ID: 11362046
    [No Abstract]   [Full Text] [Related]  

  • 42. Long-term efficacy and safety of twice-daily saquinavir soft gelatin capsules (SGC), with or without nelfinavir, and three times daily saquinavir-SGC, in triple combination therapy for HIV infection: 100-week follow-up.
    Greenberg RN; Feinberg J; Goodrich J; Pilson RS; Siemon-Hryczyk P
    Antivir Ther; 2003 Feb; 8(1):37-42. PubMed ID: 12713062
    [TBL] [Abstract][Full Text] [Related]  

  • 43. NNRTI plus PI combinations in the perspective of nucleoside-sparing or nucleoside-failing antiretroviral regimens.
    Joly V; Descamps D; Yeni P
    AIDS Rev; 2002; 4(3):128-39. PubMed ID: 12416447
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Efavirenz (Sustiva) on fast-track for FDA accelerated approval. Food and Drug Administration.
    Baker R
    BETA; 1998 Jul; ():9. PubMed ID: 11365571
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delavirdine gets the green light.
    Vazquez E
    Posit Aware; 1997; 8(3):18-9. PubMed ID: 11364419
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The 48-week efficacy of once-daily saquinavir/ritonavir in patients with undetectable viral load after 3 years of antiretroviral therapy.
    Cardiello P; Srasuebkul P; Hassink E; Mahanontharit A; Samor T; Ruxrungtham K; Lange J; Cooper D; Phanuphak P
    HIV Med; 2005 Mar; 6(2):122-8. PubMed ID: 15807718
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Protease inhibitors at a glance...
    Notes Undergr; 1998-1999 Winter; (No 38):suppl 1-4. PubMed ID: 11366198
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opportunistic pricing: a new scourge, a new call for action.
    Proj Inf Perspect; 1998 Dec; (26):1-5. PubMed ID: 11366486
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of low-dose boosted saquinavir once daily plus nucleoside reverse transcriptase inhibitors in pregnant HIV-1-infected women with a therapeutic drug monitoring strategy.
    Lopez-Cortes LF; Ruiz-Valderas R; Rivero A; Camacho A; Marquez-Solero M; Santos J; García-Lazaro M; Viciana P; Rodriguez-Baños J; Ocampo A
    Ther Drug Monit; 2007 Apr; 29(2):171-6. PubMed ID: 17417070
    [TBL] [Abstract][Full Text] [Related]  

  • 50. FDA advisory committee deadlocks on delavirdine. Food and Drug Administration.
    Mascolini M
    AIDS Treat News; 1996 Dec; (No 260):3-5. PubMed ID: 11364022
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Gynecomastia and HAART.
    Post JJ
    AIDS Read; 2000 May; 10(5):314. PubMed ID: 10851722
    [No Abstract]   [Full Text] [Related]  

  • 52. A note about Viagra.
    Treat Rev; 1998; (No 28):15. PubMed ID: 11365423
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Now approved: Sustiva in combination offers patients a new first-line therapy.
    Fac Notes (New Orleans La); 1998; 10(6):10. PubMed ID: 11366140
    [TBL] [Abstract][Full Text] [Related]  

  • 54. HIV therapeutics: past, present, and future.
    Abu-ata O; Slim J; Perez G; Smith SM
    Adv Pharmacol; 2000; 49():1-40. PubMed ID: 11013759
    [No Abstract]   [Full Text] [Related]  

  • 55. New drugs--reports of new drugs recently approved by the FDA. Saquinavir.
    Bioorg Med Chem; 1997 Mar; 5(3):465-6. PubMed ID: 9113323
    [No Abstract]   [Full Text] [Related]  

  • 56. Three days that shook the world.
    Gilden D; Smart T
    GMHC Treat Issues; 1996 Mar; 10(3):1-5. PubMed ID: 11363388
    [TBL] [Abstract][Full Text] [Related]  

  • 57. '96-'97 new drugs and the nominees for 1997 are...
    Notes Undergr; 1997; (No 35):suppl 1-2. PubMed ID: 11364566
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Side-effects of ritonavir and its combination with saquinavir with special regard to renal function.
    Witzke O; Plentz A; Schäfers RF; Reinhardt W; Heemann U; Philipp T
    AIDS; 1997 May; 11(6):836-8. PubMed ID: 9143629
    [No Abstract]   [Full Text] [Related]  

  • 59. Delavirdine gets FDA approval. Food and Drug Administration.
    AIDS Alert; 1997 Jun; 12(6):70. PubMed ID: 11364363
    [TBL] [Abstract][Full Text] [Related]  

  • 60. DMP 266 (Sustiva) expanded access.
    Vazquez E; Whitfield L
    Posit Aware; 1997; 8(6):12. PubMed ID: 11364850
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.